JP2010209101A5 - - Google Patents

Download PDF

Info

Publication number
JP2010209101A5
JP2010209101A5 JP2010107880A JP2010107880A JP2010209101A5 JP 2010209101 A5 JP2010209101 A5 JP 2010209101A5 JP 2010107880 A JP2010107880 A JP 2010107880A JP 2010107880 A JP2010107880 A JP 2010107880A JP 2010209101 A5 JP2010209101 A5 JP 2010209101A5
Authority
JP
Japan
Prior art keywords
use according
liver
medicament
primary tumor
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010107880A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010209101A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010209101A publication Critical patent/JP2010209101A/ja
Publication of JP2010209101A5 publication Critical patent/JP2010209101A5/ja
Pending legal-status Critical Current

Links

JP2010107880A 2001-10-01 2010-05-10 転移阻害のための方法 Pending JP2010209101A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32628801P 2001-10-01 2001-10-01
US60/326,288 2001-10-01

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003531978A Division JP5280603B2 (ja) 2001-10-01 2002-10-01 転移阻害のための方法

Publications (2)

Publication Number Publication Date
JP2010209101A JP2010209101A (ja) 2010-09-24
JP2010209101A5 true JP2010209101A5 (enExample) 2011-07-28

Family

ID=23271590

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003531978A Expired - Fee Related JP5280603B2 (ja) 2001-10-01 2002-10-01 転移阻害のための方法
JP2010107880A Pending JP2010209101A (ja) 2001-10-01 2010-05-10 転移阻害のための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2003531978A Expired - Fee Related JP5280603B2 (ja) 2001-10-01 2002-10-01 転移阻害のための方法

Country Status (6)

Country Link
US (2) US6753328B2 (enExample)
EP (1) EP1450814B1 (enExample)
JP (2) JP5280603B2 (enExample)
AU (1) AU2002362459B2 (enExample)
CA (1) CA2462564C (enExample)
WO (1) WO2003028642A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6753328B2 (en) * 2001-10-01 2004-06-22 Rhode Island Hospital Methods of inhibiting metastases
WO2004094823A2 (en) 2003-04-23 2004-11-04 Biovalve Technologies, Inc. Hydraulically actuated pump for long duration medicament administration
US9089636B2 (en) 2004-07-02 2015-07-28 Valeritas, Inc. Methods and devices for delivering GLP-1 and uses thereof
JP2009532117A (ja) 2006-03-30 2009-09-10 ヴァレリタス,エルエルシー マルチカートリッジ式流体投与装置
CN101528195B (zh) * 2006-09-07 2012-03-28 埃德盖斯特利希索恩化学工业股份公司 羟甲基转移剂在制备治疗骨癌的药物中的用途
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
WO2011011688A2 (en) 2009-07-24 2011-01-27 Rhode Island Hospital DENDRITIC CELL VACCINES FOR ASPARAGINYL- β - HYDROXYLASE EXPRESSING TUMORS
US11738120B1 (en) 2022-04-14 2023-08-29 Cormedix Inc. Synthesis of taurolidine, purity profiles and polymorphs

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124285A (en) 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
GB1408010A (en) 1972-11-20 1975-10-01 Geistlich Soehne Ag Sulphamoylphenyl-imidazolidinones
GB1557163A (en) 1975-06-24 1979-12-05 Geistlich Soehne Ag Dental care preparations
US4107305A (en) 1975-08-04 1978-08-15 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Treatment of endotoxaemia
GB1588110A (en) 1978-05-31 1981-04-15 Geistlich Soehne Ag Pharmaceutical compositions for the treatment of scars
US4337251A (en) 1979-05-09 1982-06-29 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of avoiding and removing adhesions
CA1190855A (en) 1980-09-03 1985-07-23 Rolf W. Pfirrmann Treatment of osteitis
GB8328073D0 (en) 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
GB8328111D0 (en) 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
GB8328074D0 (en) 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compositions
US5210083A (en) 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
GB8617482D0 (en) 1986-07-17 1986-08-28 Geistlich Soehne Ag Pharmaceutical composition
US5573771A (en) 1988-08-19 1996-11-12 Osteomedical Limited Medicinal bone mineral products
US5069662A (en) * 1988-10-21 1991-12-03 Delcath Systems, Inc. Cancer treatment
US5819748A (en) 1988-11-30 1998-10-13 Ed Geistlich Sohne Ag Fur Chemische Industrie Implant for use in bone surgery
GB8827986D0 (en) 1988-11-30 1989-01-05 Geistlich Soehne Ag Chemical product
GB9005856D0 (en) 1990-03-15 1990-05-09 Geistlich Soehne Ag Compositions
GB9015108D0 (en) 1990-07-09 1990-08-29 Geistlich Soehne Ag Chemical compositions
US5635532A (en) 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
GB9216155D0 (en) 1992-07-30 1992-09-09 Geistlich Soehne Ag Treatment of dentoalveolar infections
US5954687A (en) 1995-04-28 1999-09-21 Medtronic, Inc. Burr hole ring with catheter for use as an injection port
US5976822A (en) 1995-05-18 1999-11-02 Coulter International Corp. Method and reagent for monitoring apoptosis and distinguishing apoptosis from necrosis
GB9600426D0 (en) 1996-01-10 1996-03-13 Ed Geistlich Sohne A G Compositions
AU734460B2 (en) 1997-05-22 2001-06-14 Oklahoma Medical Research Foundation Use of taurolidine for treatment of leukemias
US6479481B1 (en) 1999-06-04 2002-11-12 Ed. Geistlich Soehne Ag Fur Chemische Industrie Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
US7151099B2 (en) 1998-07-31 2006-12-19 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Use of taurolidine and/or taurultam for treatment of abdominal cancer and/or for the prevention of metastases
GB9716219D0 (en) * 1997-07-31 1997-10-08 Geistlich Soehne Ag Prevention of metastases
US6011030A (en) 1997-09-22 2000-01-04 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating symptoms of microbial infection or sepsis
US5972933A (en) 1998-01-08 1999-10-26 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating microbial infections
US6117868A (en) 1998-09-16 2000-09-12 Ed. Geistlich Sohne Ag Fur Chemische Industrie Treatment of gastrointestinal ulcers or gastritis caused by microbial infection
US20020098164A1 (en) * 2000-10-27 2002-07-25 Redmond H. Paul Treatment of tumor metastases and cancer
SE516215C2 (sv) * 1999-07-10 2001-12-03 Argmed Kb Perfusionssystem samt pumpanordning och styrsystem för användning i perfusionssystemet
CA2393252A1 (en) 1999-12-06 2001-06-07 Paul Calabresi Use of methylol-containing compounds to treat tumors
CA2363973C (en) * 2000-11-28 2009-03-10 Ed. Geistlich Sohne Ag Fur Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
US6753328B2 (en) * 2001-10-01 2004-06-22 Rhode Island Hospital Methods of inhibiting metastases

Similar Documents

Publication Publication Date Title
JP2010209101A5 (enExample)
JP2013534535A5 (enExample)
EP2506850A4 (en) METHOD FOR THE ADMINISTRATION OF PIRFENIDON THERAPY
NZ601167A (en) Treatment of cardiac conditions
IL212064A (en) Use of pirpenidone in the preparation of a drug for the treatment of patients with atypical liver function
MX2012012952A (es) Compuestos de 2, 5, 6, 7,-tetrahidro-[1, 4] oxazepin-3-ilamina o 2, 3, 6, 7-tetrahidro-[1, 4] oxazepin-5-ilamina.
JP2012136540A5 (enExample)
JP2011516501A5 (enExample)
BRPI0911520A2 (pt) novas aproximações terapêuticas para o tratamento da doença de alzheimer e doenças relacionadas através de uma modulação de angiogênese.
JP2014193925A5 (enExample)
JP2015536964A5 (enExample)
EA200901170A1 (ru) Органические соединения и их применение
IL217901B (en) Use of laquinimod or a laquinimod salt in the manufacture of a drug for the treatment of bdnf-related diseases
JP2011157399A5 (enExample)
WO2012117257A8 (en) Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
EA201071006A1 (ru) Набор, композиция, продукт или лекарственное средство для лечения нарушения познавательной способности
PH12012502129A1 (en) New combination therapy in treatment of oncological and fibrotic diseases
NZ700872A (en) Prophylactic or therapeutic agent for giant cell tumors occurring in bone and soft tissue or for chondrosarcoma
JP2013541583A5 (enExample)
NZ602029A (en) Use of meloxicam for the long-term treatment of kidney disorders in cats
EA201401231A1 (ru) Фармацевтические комбинации, предназначенные для лечения метаболических нарушений
JP2013166781A5 (enExample)
JP2012516348A5 (enExample)
SI2415475T1 (sl) Farmacevtski pripravek, ki obsega inhibitor protonske ÄŤrpalke ter prebiotik za zdravljenje ulceroznih lezij Ĺľelodca in dvanajsternika
IT1401667B1 (it) Capsula ingeribile per l'insufflazione del tratto gastrointestinale.